BAX - Baxter International Inc.
90.01 0.00 (0.00%)
After hours: 4:55PM EDT
| Previous close | 88.20 |
| Open | 88.60 |
| Bid | 88.49 x 1300 |
| Ask | 90.06 x 900 |
| Day's range | 87.85 - 90.11 |
| 52-week range | 69.10 - 95.19 |
| Volume | 2,605,864 |
| Avg. volume | 3,543,911 |
| Market cap | 45.8B |
| Beta (5Y monthly) | 0.78 |
| PE ratio (TTM) | 47.18 |
| EPS (TTM) | 1.91 |
| Earnings date | 23 Jul 2020 - 27 Jul 2020 |
| Forward dividend & yield | 0.98 (1.11%) |
| Ex-dividend date | 04 Jun 2020 |
| 1y target est | 97.00 |
- Zacks
Baxter Receives CE Marking for Evo IQ Syringe Infusion System
Baxter (BAX) receives the CE marking and regulatory approval for the Evo IQ Syringe Infusion system that will help in optimizing efficiency for clinicians.
- Business Wire
Baxter Receives CE Marking and Australian Regulatory Approval for Evo IQ Syringe Infusion System, Building on Smart Pump Platform
Baxter International Inc. (NYSE:BAX), a leader in innovative technology for medication delivery, today announced CE marking and regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for the Evo IQ Syringe Infusion System. The company expects hospitals in the United Kingdom, Ireland, Greece, Australia and New Zealand to be among the first to receive the new system, with additional countries to follow in a series of planned regulatory submissions.
- Business Wire
Baxter Announces Results of Clinical Trial on Benefits of Dynamic Fluid Management in Septic Shock Patients
Results published in the CHEST Journal demonstrate benefits of using dynamic measures to guide fluid therapy decisions.
- Business Wire
Baxter Increases Dividend and Declares Quarterly Dividend
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced an increase in the company’s quarterly cash dividend to a rate of $0.245 per share of common stock. This represents an approximately 11% increase over the previous quarterly dividend rate of $0.22 per share. Baxter’s Board of Directors declared the dividend payable on July 1, 2020, to stockholders of record as of June 5, 2020. The indicated annual dividend rate is now $0.98 per share of common stock.
- Motley Fool
Baxter International Inc (BAX) Q1 2020 Earnings Call Transcript
Joining me today are Joe Almeida, Baxter's Chairman and Chief Executive Officer; and Jay Saccaro, Baxter's Chief Financial Officer. On the call this morning, we will be discussing Baxter's first quarter 2020 financial results.
- Motley Fool
Baxter Beats Q1 Estimates as COVID-19 Boosts Sales
The giant healthcare company saw increased demand in Q1 for several products due to the coronavirus pandemic.
- Zacks
Baxter (BAX) Q1 Earnings and Revenues Surpass Estimates
Baxter's (BAX) first-quarter earnings benefit from solid segmental performance and growth across all geographies.
- Business Wire
Baxter Reports First-Quarter 2020 Results
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the first quarter of 2020.
- Zacks
Medical Products Stock Earnings on Apr 30: BAX, IDXX & More
The medical product companies have partially mitigated the impact of the pandemic driven by the massive adoption of COVID-19 related healthcare-support products and services.
- Business Wire
Baxter to Present at the UBS Virtual Global Healthcare Conference
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the UBS Virtual Global Healthcare Conference on Tuesday, May 19, 2020 via webcast. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 10:00 a.m. Eastern Time.
- Zacks
Baxter (BAX) to Report Q1 Earnings: What's in the Offing?
Baxter's (BAX) first-quarter performance is likely to reflect growth in its six global business units.
- Zacks
ABIOMED (ABMD) to Report Q4 Earnings: What's in the Cards?
ABIOMED's (ABMD) fiscal fourth-quarter performance is likely to reflect growth in Impella product line.
- Business Wire
Baxter to Present at the Virtual BofA Securities 2020 Health Care Conference
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the virtual BofA Securities 2020 Health Care Conference via webcast on Tuesday, May 12, 2020. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 10:20 a.m. Eastern Time.
- Business Wire
Baxter Obtains U.S. FDA Emergency Use Authorization for Oxiris Blood Purification Filter for COVID-19 Treatment
Baxter International Inc. (NYSE:BAX), a global leader in acute care, announced it has received emergency use authorization (EUA) from the U.S. FDA for the company’s Oxiris filter set to treat patients who have confirmed COVID-19 and have been admitted to the intensive care unit (ICU) with confirmed or imminent respiratory failure in need of blood purification therapy to reduce pro-inflammatory cytokine levels, including use in continuous renal replacement therapy (CRRT).
- Business Wire
Baxter to Host First-Quarter 2020 Financial Results Conference Call for Investors
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its first-quarter 2020 financial results on Thursday, April 30, 2020, at 7:30 a.m. Central Time.
- Zacks
Why Baxter (BAX) is Poised to Beat Earnings Estimates Again
Baxter (BAX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- Zacks
Baxter (BAX) Up 2.7% Since Last Earnings Report: Can It Continue?
Baxter (BAX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Business Wire
Baxter Provides Update on COVID-19 Response Efforts
Baxter International Inc. (NYSE:BAX), a global medical products company, today provided an update on how the company is responding to the COVID-19 epidemic that is challenging communities and healthcare systems throughout the world. The company’s support remains focused on increasing supply of its life-sustaining medicines and medical devices amidst unprecedented, rising demand; protecting employee health and safety; expanding job opportunities globally to help meet increased product demand; and providing philanthropic grants to support impacted communities.
- Business Wire
Baxter To Host Its Annual Meeting Of Stockholders In Virtual Format
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that, due to the public health and safety concerns related to the novel coronavirus (COVID-19) pandemic and recommendations and orders from Federal and Illinois authorities, its Annual Meeting of Stockholders (the 2020 Annual Meeting) will now be held by means of a virtual format only.
- Zacks
Baxter (BAX) Looks Good: Stock Adds 5.1% in Session
Baxter (BAX) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
- Zacks
Here's Why You Should Hold Onto Baxter (BAX) Stock for Now
Baxter (BAX) issues strong guidance for the first quarter of 2020.
- Zacks
Baxter (BAX) Q4 Earnings Beat Estimates, Revenues In Line
Baxter's (BAX) fourth-quarter earnings benefit from higher revenues, solid segmental performance and growth in APAC.
- Business Wire
Baxter Reports Fourth-Quarter and Full-Year 2019 Results, Completes Financial Restatement Process
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced its complete financial results for the fourth quarter and full year ended December 31, 2019. In addition, the company announced the filing of its Annual Report on Form 10-K for the year ended December 31, 2019 (the Form 10-K), which includes audited restated financial statements as of December 31, 2018 and for the years ended December 31, 2018 and 2017, and its Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 (the 3Q Form 10-Q). The company has now completed its internal investigation into certain intra-company transactions that impacted its previously reported non-operating foreign exchange gains and losses as it relates to the financial statement impacts. With these filings, Baxter is now current in its SEC reporting obligations.
- Business Wire
Baxter to Host Fourth-quarter 2019 Financial Results Conference Call for Investors
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its fourth-quarter 2019 financial results on Tuesday, March 17, 2020, at 7:30 a.m. Central Time.
- Zacks
Why Earnings Season Could Be Great for Baxter (BAX)
Baxter (BAX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
